MedTrace Logo

EUROPT Clinical Trial to Study the Efficacy of One-Way Valve Implantation (New Treatment Algorithm) in Patients With Heterogeneous Emphysema

NCT00730301 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2008-08-08

No results posted yet for this study

Summary

The purpose of this study is to assess the efficacy of a new treatment algorithm for bronchoscopic lung volume reduction (BLVR) in patients with emphysema based on the information of emphysema heterogeneity, destruction score, and fissure analysis.

Conditions

Interventions

PROCEDURE

Bronchoscopic Lung Volume Reduction (BLVR)

Procedure under general anesthesia.

Sponsors & Collaborators

  • LudwLudwig Boltzmann Institute for COPD and Respiratory Epidemiology

    lead NETWORK

Principal Investigators

  • Arschang Valipour, MD · Ludwig Boltzmann Institute for COPD

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2008-09-30

Countries

  • Austria
  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00730301 on ClinicalTrials.gov